Number of the records: 1
FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells
- 1.Štefánik, M., Valdés, J. J., Ezebuo, F.C., Haviernik, J., Uzochukwu, I.C., Fojtiková, M., Salát, J., Eyer, L., Růžek, D. FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells. Microorganisms. 2020, 8(4), 599. E-ISSN 2076-2607. Available: doi: 10.3390/microorganisms8040599.
Number of the records: 1